文献速递瓣膜外科主动脉外科

无支架主动脉瓣置换术后再干预的手术风险评估

Reinterventions after freestyle stentless aortic valve replacement: an assessment of procedural risks.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

本研究回顾性分析1993年至2018年75例既往Freestyle无支架生物瓣主动脉瓣置换术后再干预患者,中位年龄62岁,再干预指征包括结构性瓣膜退化47例、非结构性13例、心内膜炎15例。早期死亡率为9.3%,近十年择期再手术28例中为零;10年总生存率69%(95%CI 53-81%)。结论认为再干预早期死亡风险增高但可接受,瓣中瓣术后需注意冠脉阻塞风险。

要点

  • 无支架主动脉瓣置换术后再干预早期死亡率为9.3%,近十年择期再手术为零。
  • 再干预方式中根部替换占68%,早期死亡率最低(6%)。
  • 瓣中瓣术后需警惕冠状动脉阻塞,本组经导管主动脉瓣置换早期死亡2例。

核心结论

  • 无支架主动脉瓣置换术后再干预的早期死亡风险增高但可接受。
  • 经导管瓣中瓣术后需仔细评估瓣叶位置以避免冠状动脉阻塞。

研究设计与样本

  • 回顾性分析1993年至2018年单中心75例既往Freestyle无支架生物瓣主动脉瓣置换术后再干预患者。
  • 既往手术方式包括31例瓣下、15例根部包入和29例全根部替换。
  • 围术期数据回顾性收集,随访数据前瞻性收集。

主要发现

  • 再干预指征为结构性瓣膜退化47例、非结构性13例、心内膜炎15例。
  • 24例(32%)需急诊手术;再干预方式为外科主动脉瓣置换16例(21%)、根部替换51例(68%)、经导管主动脉瓣置换8例(11%)。
  • 早期死亡7例(9.3%),按指征分别为结构性瓣膜退化9%、非结构性8%、心内膜炎13%。
  • 根部替换早期死亡率最低(6%),外科主动脉瓣置换13%,经导管主动脉瓣置换25%(2例冠状动脉阻塞)。
  • 起搏器植入率7%;10年总生存率69%(95%CI 53-81%)。

关键数值与推荐

  • 中位年龄62岁(四分位距47-72岁)。
  • 近十年择期再手术28例中早期死亡为零。

临床怎么用

  • 无支架主动脉瓣置换术后再干预应个体化评估,择期手术可降低早期死亡风险。
  • 经导管瓣中瓣术前需仔细评估瓣叶位置以预防冠状动脉阻塞。

局限性

  • 单中心回顾性研究,样本量较小(75例)。
  • 围术期数据回顾性收集,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Repeat aortic valve interventions after previous stentless aortic valve replacement (AVR) are considered technically challenging with an increased perioperative risk, especially after full-root replacement. We analysed our experience with reinterventions after stentless AVR. METHODS: A total of 75 patients with previous AVR using a Freestyle stentless bioprosthesis (31 subcoronary, 15 root-inclusion and 29 full-root replacement) underwent reintervention in our centre from 1993 until December 2018. Periprocedural data were retrospectively collected from the department database and follow-up data were prospectively collected. RESULTS: Median age was 62 years (interquartile range 47-72 years). Indications for reintervention were structural valve deterioration (SVD) in 47, non-SVD in 13 and endocarditis in 15 patients. Urgent surgery was required in 24 (32%) patients. Reinterventions were surgical AVR in 16 (21%), root replacement in 51 (68%) and transcatheter AVR in 8 (11%) patients. Early mortality was 9.3% (n = 7), but decreased to zero in the past decade in 28 patients undergoing elective reoperation. Per indication, early mortality was 9% for SVD, 8% for non-SVD and 13% for endocarditis. Aortic root replacement had the lowest early mortality rate (6%), followed by surgical AVR (13%) and transcatheter AVR (25%, 2 patients with coronary artery obstruction). Pacemaker implantation rate was 7%. Overall survival rate at 10 years was 69% (95% confidence interval 53-81%). CONCLUSIONS: Repeat aortic valve interventions after stentless AVR carry an increased, but acceptable, early mortality risk. Transcatheter valve-in-valve procedures after stentless AVR require careful consideration of prosthesis leaflet position to prevent obstruction of the coronary arteries.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Schneider AW, Hazekamp MG, Versteegh MIM, et al. Reinterventions after freestyle stentless aortic valve replacement: an assessment of procedural risks. Eur J Cardiothorac Surg. 2019. PMID: 31424504. doi:10.1093/ejcts/ezz222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。